Chrome Extension
WeChat Mini Program
Use on ChatGLM

MO01.48 INSIGHT 2: Tepotinib + Osimertinib in EGFR-Mutant NSCLC with Resistance to 1St-Line Osimertinib Due to MET Amplification

Journal of Thoracic Oncology(2021)

Cited 0|Views27
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined